As of 2025-07-06, the Intrinsic Value of Tianshui Zhongxing Bio-technology Co Ltd (002772.SZ) is 4.15 CNY. This 002772.SZ valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 7.94 CNY, the upside of Tianshui Zhongxing Bio-technology Co Ltd is -47.80%.
The range of the Intrinsic Value is 2.49 - 7.51 CNY
Based on its market price of 7.94 CNY and our intrinsic valuation, Tianshui Zhongxing Bio-technology Co Ltd (002772.SZ) is overvalued by 47.80%.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | 2.49 - 7.51 | 4.15 | -47.8% |
| DCF (Growth 10y) | 2.92 - 7.54 | 4.46 | -43.9% |
| DCF (EBITDA 5y) | 20.14 - 23.44 | 22.59 | 184.6% |
| DCF (EBITDA 10y) | 20.24 - 25.04 | 23.36 | 194.2% |
| Fair Value | 8.99 - 8.99 | 8.99 | 13.28% |
| P/E | 3.97 - 8.18 | 6.05 | -23.7% |
| EV/EBITDA | 4.19 - 7.21 | 6.12 | -22.9% |
| EPV | (5.73) - (6.24) | (5.99) | -175.4% |
| DDM - Stable | 2.43 - 5.45 | 3.94 | -50.4% |
| DDM - Multi | 4.05 - 6.58 | 4.98 | -37.3% |
| Market Cap (mil) | 3,122.33 |
| Beta | 0.82 |
| Outstanding shares (mil) | 393.24 |
| Enterprise Value (mil) | 4,302.98 |
| Market risk premium | 6.13% |
| Cost of Equity | 11.14% |
| Cost of Debt | 5.00% |
| WACC | 7.95% |